How Is Frontotemporal Dementia Different from Alzheimer’s?
How Is Frontotemporal Dementia Different from Alzheimer’s? One of the primary differences between FTD and Alzheimer’s is the pattern of symptoms. Frontotemporal Dementia typically manifests with changes in behavior, language difficulties, and emotional instability. In contrast, Alzheimer’s disease is characterized by memory loss, cognitive decline, and difficulty with problem-solving.
The progression of these conditions also differs. Frontotemporal Dementia tends to develop earlier in life, usually between the ages of 40 and 65, whereas Alzheimer’s disease is more common in individuals over the age of 65. This distinction has a significant impact on the overall prognosis and care needs for those affected.
Treatment approaches for FTD and Alzheimer’s also vary. While there is currently no cure for either condition, medications and therapies can help manage symptoms, improve quality of life, and slow down the progression of Alzheimer’s disease. In contrast, there are fewer treatment options available specifically for Frontotemporal Dementia.
Get Free Consultation
ACIBADEM Health Point: The Future of Healthcare
We believe that everyone deserves access to quality healthcare, which is why we have established multiple branches in strategic locations. Whether you're in need of routine check-ups, specialized treatments, or emergency care, ACIBADEM Health Point is here for you.Outcomes for individuals with FTD and Alzheimer’s can also differ. Alzheimer’s disease generally leads to a gradual decline in cognitive function, eventually interfering with daily activities and independence. On the other hand, Frontotemporal Dementia often presents more severe behavioral changes, impacting social interactions and relationships.
As we delve into the details of Frontotemporal Dementia and Alzheimer’s disease in the following sections, we will explore their symptoms, causes, diagnosis, progression, treatment options, and the overall impact on individuals and their caregivers. By understanding these differences, we can better support those affected by these conditions and work towards advancements in research and treatment.
Understanding Frontotemporal Dementia
Frontotemporal Dementia (FTD) is a neurodegenerative disorder that primarily affects the frontal and temporal lobes of the brain. This condition is characterized by progressive changes in behavior, language, and personality. Understanding the symptoms, causes, and diagnosis of FTD is essential for accurate identification and management of the disease.
ACIBADEM Health Point: Your Health is Our Priority!
ACIBADEM Health Point, we are dedicated to providing exceptional healthcare services to our patients. With a team of highly skilled medical professionals and state-of-the-art facilities, we strive to deliver the highest standard of care to improve the health and well-being of our patients. What sets ACIBADEM Health Point apart is our patient-centered approach. We prioritize your comfort, safety, and satisfaction throughout your healthcare journey. Our compassionate staff ensures that you receive personalized care tailored to your unique needs, making your experience with us as seamless and comfortable as possible.Symptoms of Frontotemporal Dementia
Frontotemporal Dementia presents with a variety of symptoms that can manifest differently in each individual. Common behavioral and cognitive changes observed in FTD include:
- Disinhibition and impulsive behavior
- Social withdrawal and apathy
- Language difficulties and speech problems
- Loss of empathy and emotional blunting
- Executive dysfunction and impaired decision-making
These symptoms often appear gradually and progressively worsen over time, impacting an individual’s daily functioning and interpersonal relationships.
Causes of Frontotemporal Dementia
The exact causes of Frontotemporal Dementia are not yet fully understood. However, research suggests a combination of genetic factors and abnormal protein deposits in the brain contribute to the development of the disease. Mutations in certain genes, such as MAPT and C9orf72, have been linked to a higher risk of FTD.
Diagnosis of Frontotemporal Dementia
Diagnosing Frontotemporal Dementia can be challenging, as its symptoms may overlap with other neurodegenerative disorders like Alzheimer’s disease. Medical professionals use a combination of clinical evaluations, neurological exams, and brain imaging techniques to determine the presence of FTD. Additional tests, such as genetic testing and neuropsychological assessments, may also be employed to support the diagnosis.
Early and accurate diagnosis is crucial for appropriate treatment planning and support for individuals with Frontotemporal Dementia.
Exploring Alzheimer’s Disease
Alzheimer’s disease is a progressive neurological disorder that primarily affects memory, thinking, and behavior. It is the most common cause of dementia, accounting for approximately 60-80% of all cases.
Symptoms
The symptoms of Alzheimer’s can vary from person to person but generally include:
- Memory loss that disrupts daily life
- Difficulty in planning or problem-solving
- Confusion with time or place
- Changes in mood or personality
- Trouble completing familiar tasks
- Difficulty in communication
Causes
The exact cause of Alzheimer’s disease is not yet fully understood. However, it is believed to be caused by a combination of genetic, environmental, and lifestyle factors. The buildup of abnormal proteins in the brain, such as amyloid plaques and tau tangles, is thought to play a significant role in the development of the disease.
Diagnosis
The diagnosis of Alzheimer’s disease involves a thorough evaluation of medical history, cognitive tests, and imaging scans. Healthcare professionals also consider the exclusion of other possible causes of dementia. It is essential to differentiate Alzheimer’s from other forms of dementia, such as Frontotemporal Dementia (FTD), due to differences in symptoms and treatment approaches.
Comparison of Alzheimer’s and Frontotemporal Dementia (FTD)
| Aspect | Alzheimer’s Disease | Frontotemporal Dementia (FTD) |
|---|---|---|
| Symptoms | Memory impairment, cognitive decline, confusion | Behavioral changes, language difficulties, executive dysfunction |
| Age of Onset | Most common in older adults (65+) | Can occur in younger adults ( |
| Underlying Pathology | Abnormal protein accumulation (amyloid plaques, tau tangles) | Protein accumulation in frontotemporal brain regions |
| Treatment | Medications to manage symptoms, supportive care | Treatment of specific symptoms (e.g., behavioral interventions, speech therapy) |
Source: Adapted from Alzheimer’s Association and Association for Frontotemporal Degeneration
While Alzheimer’s disease and Frontotemporal Dementia share some similarities, they are distinct disorders with different symptom profiles and underlying pathologies. Understanding these differences is crucial for accurate diagnosis and appropriate treatment strategies.
Differentiating Symptoms of FTD and Alzheimer’s
Frontotemporal Dementia (FTD) and Alzheimer’s disease are both neurodegenerative conditions that impact cognitive function and behavior. While they share certain similarities, there are distinct differences in the symptoms exhibited by individuals with these diseases.
Symptoms of Frontotemporal Dementia (FTD)
FTD primarily affects the frontal and temporal lobes of the brain, resulting in behavioral and personality changes. Some common symptoms of FTD include:
- Early onset of symptoms, typically between the ages of 40 and 65
- Loss of empathy and social awareness
- Impulsive or inappropriate behavior
- Decline in language skills, including difficulty speaking or understanding words
- Executive dysfunction, such as trouble with planning, organizing, and decision-making
Symptoms of Alzheimer’s Disease
In contrast, Alzheimer’s disease primarily affects the hippocampus and other areas of the brain, leading to memory loss and cognitive decline. Some common symptoms of Alzheimer’s include:
- Memory loss, particularly for recent events
- Confusion and disorientation, especially in familiar surroundings
- Trouble finding words or expressing thoughts
- Difficulty completing familiar tasks
- Changes in mood and behavior, such as anxiety, depression, or aggression
It’s important to note that these symptoms can vary from person to person, and some individuals may experience a combination of symptoms associated with both FTD and Alzheimer’s. A comprehensive evaluation by a healthcare professional is essential for an accurate diagnosis and appropriate management of these conditions.
By understanding the unique symptoms of Frontotemporal Dementia and Alzheimer’s, individuals, families, and healthcare providers can better navigate the challenges associated with these diseases and tailor care and support accordingly.
Progression of FTD and Alzheimer’s
As neurodegenerative diseases, both Frontotemporal Dementia (FTD) and Alzheimer’s disease exhibit distinct patterns of progression over time. Understanding the progression of these conditions is crucial for providing proper care and support to individuals affected by them.
1. Frontotemporal Dementia Progression
In Frontotemporal Dementia, the progression typically follows a pattern of gradual deterioration in behavior, language, and personality. This form of dementia primarily affects the frontal and temporal lobes of the brain, leading to significant changes in cognitive and emotional functioning.
Behavioral Changes: In the early stages, individuals with FTD may experience alterations in their personality, showing a lack of empathy, impulsivity, and socially inappropriate behaviors. As the disease progresses, they may exhibit apathy, disinhibition, and increased rigidity in thinking and problem-solving abilities.
Language Impairment: Language difficulties are a hallmark of FTD. Individuals may have trouble finding the right words, struggle with grammar and syntax, and exhibit speech hesitations. Understanding and interpreting language can become increasingly challenging as the disease advances.
Motor Manifestations: In some cases of FTD, individuals may develop movement disorders, such as muscle stiffness, tremors, and difficulty with coordination. These motor symptoms can coexist with cognitive and behavioral changes, further impacting daily functioning.
2. Alzheimer’s Disease Progression
Alzheimer’s disease, on the other hand, follows a more predictable and gradual decline in memory and cognitive abilities. It primarily affects the hippocampus and other areas of the brain involved in memory consolidation and retrieval.
Memory Loss: The most evident and early symptom of Alzheimer’s is short-term memory loss. Individuals may struggle to remember recent events, names, and conversations. As the disease progresses, long-term memory is also affected, leading to significant gaps in a person’s recall of past experiences.
Cognitive Decline: Alzheimer’s gradually impairs various cognitive functions, including problem-solving, decision-making, attention, and language comprehension. Individuals may have difficulty following instructions, participating in conversations, and performing complex tasks.
Functional Impairment: As Alzheimer’s progresses, individuals may struggle with activities of daily living, such as dressing, eating, and bathing. They may become increasingly dependent on others for assistance and require specialized care.
| Frontotemporal Dementia | Alzheimer’s Disease | |
|---|---|---|
| Progression Pattern | Gradual deterioration in behavior, language, and personality | Gradual decline in memory and cognitive abilities |
| Behavioral Changes | Lack of empathy, impulsivity, socially inappropriate behaviors | Memory loss, difficulty with problem-solving, decision-making |
| Language Impairment | Trouble finding words, grammar and syntax difficulties | Difficulty with language comprehension, speech hesitations |
| Movement Manifestations | Muscle stiffness, tremors, coordination difficulties | – |
While the progression of Frontotemporal Dementia and Alzheimer’s disease may share some overlapping features, the distinct patterns of cognitive decline and functional impairment in each condition necessitate individualized care and support strategies. It is crucial to consult with healthcare professionals for accurate diagnosis, appropriate treatment, and effective management of these progressive neurodegenerative disorders.
Treatment Approaches for FTD and Alzheimer’s
When it comes to managing Frontotemporal Dementia (FTD) and Alzheimer’s disease, treatment options aim to alleviate symptoms, slow down progression, and improve the overall quality of life for patients. These treatment approaches vary depending on the specific condition and individual needs.
Treatment for Frontotemporal Dementia
In the case of Frontotemporal Dementia, treatment primarily focuses on addressing the behavioral and psychological symptoms that often accompany the disease. Here are some common treatment approaches:
- Medications: Certain medications, such as selective serotonin reuptake inhibitors (SSRIs), can help manage mood disorders and reduce behavioral symptoms in FTD patients.
- Behavioral and Psychiatric Interventions: Psychotherapy, cognitive-behavioral therapy, and other forms of counseling can be beneficial in managing depression, anxiety, and other psychological symptoms associated with FTD.
- Supportive Care: Creating a supportive environment that focuses on the individual’s needs and preferences can greatly enhance their quality of life. This may include ensuring safety, establishing routines, and providing emotional support.
- Addressing Specific Symptoms: Depending on the symptoms present, healthcare professionals may recommend additional interventions such as speech therapy, occupational therapy, or physical therapy.
Treatment for Alzheimer’s Disease
Alzheimer’s disease treatment aims to slow down cognitive decline and manage symptoms, although there is currently no cure for the condition. Here are some common treatment approaches:
- Medications: Medications called cholinesterase inhibitors and memantine are often prescribed to manage cognitive symptoms, such as memory loss and confusion, associated with Alzheimer’s disease.
- Behavioral Interventions: Strategies such as cognitive stimulation therapy and reality orientation therapy can help individuals with Alzheimer’s maintain cognitive function and improve their overall well-being.
- Supportive Care: Creating a supportive and structured environment can help individuals with Alzheimer’s navigate daily activities and maintain a sense of independence for as long as possible.
- Alternative Therapies: Some individuals find complementary approaches, such as music therapy, art therapy, and aromatherapy, to be helpful in managing anxiety, depression, and other symptoms associated with the disease.
Comparing Treatments
To better understand the differences in treatment approaches between FTD and Alzheimer’s disease, let’s take a closer look at the key distinctions in the table below:
| Frontotemporal Dementia (FTD) | Alzheimer’s Disease |
|---|---|
| Focuses on managing behavioral and psychological symptoms | Targets cognitive decline and symptom management |
| Medications like SSRIs may be used to manage behavioral symptoms | Cholinesterase inhibitors and memantine may be prescribed to alleviate cognitive symptoms |
| Counseling and supportive care play a significant role in treatment | Behavioral interventions and supportive environments are emphasized to aid daily functioning |
| Specific symptom-focused therapies, such as speech or occupational therapy, may be recommended | Alternative therapies, including music or art therapy, can assist with symptom management |
It’s important to note that treatment plans should be tailored to the individual’s needs and may involve a collaborative approach involving healthcare professionals, caregivers, and support networks. Regular evaluations and adjustments to the treatment plan may be necessary to optimize outcomes and provide the best possible care for individuals with FTD or Alzheimer’s disease.
Diagnosis and Prognosis of FTD and Alzheimer’s
Accurately diagnosing Frontotemporal Dementia (FTD) and Alzheimer’s disease is crucial for guiding treatment plans and providing appropriate care. Healthcare professionals use a variety of diagnostic tests and assessments to differentiate between these two conditions and determine the best course of action for patients.
Diagnostic Process
When evaluating individuals with cognitive decline, doctors typically begin with a comprehensive medical history and physical examination. They may ask detailed questions about the onset, progression, and nature of symptoms experienced by the patient.
Afterward, further investigations may be performed to help confirm the diagnosis. These may include:
- Neuropsychological Testing: This evaluation assesses cognitive abilities, such as memory, language, problem-solving, and attention. It helps identify specific patterns of impairment associated with Frontotemporal Dementia or Alzheimer’s disease.
- Brain Imaging: Magnetic resonance imaging (MRI) or computed tomography (CT) scans provide detailed images of the brain’s structure. These imaging techniques can reveal characteristic patterns of atrophy and assist in differentiating FTD from Alzheimer’s.
- Cerebrospinal Fluid Analysis: This test involves analyzing a sample of cerebrospinal fluid obtained through a lumbar puncture. It can help identify certain biomarkers associated with Alzheimer’s disease or FTD.
- Genetic Testing: In some cases, genetic testing may be helpful, especially for individuals with a family history of FTD or Alzheimer’s. Genetic mutations, such as in the MAPT or GRN genes, are associated with increased susceptibility to FTD.
These diagnostic approaches, combined with clinical judgment, help healthcare professionals make an accurate diagnosis and differentiate between Frontotemporal Dementia and Alzheimer’s disease.
Prognosis
The prognosis for individuals diagnosed with Frontotemporal Dementia or Alzheimer’s can vary based on several factors, including the specific subtype of the disease, age of onset, and overall health status. However, both conditions generally have a progressively debilitating course.
Frontotemporal Dementia typically progresses more rapidly than Alzheimer’s, with a median survival of around 7 to 8 years after symptom onset. In contrast, Alzheimer’s disease has a more variable progression, with an average survival of 4 to 8 years for individuals aged 65 and older.
It’s important to note that prognosis is not solely determined by disease progression but also by the availability and effectiveness of treatment and supportive care options.
| Frontotemporal Dementia | Alzheimer’s Disease |
|---|---|
| Rapid progression | Variable progression |
| Median survival: 7-8 years | Median survival: 4-8 years (65 and older) |
| Distinct behavioral and personality changes | Memory loss and cognitive decline |
| Frontal and temporal lobe atrophy on brain imaging | Generalized brain atrophy on brain imaging |
Remember, early diagnosis and intervention can significantly impact the management and quality of life for individuals with Frontotemporal Dementia or Alzheimer’s. Therefore, it’s essential to seek medical attention promptly if you or a loved one are experiencing cognitive changes or other concerning symptoms.
Impact on Individuals and Caregivers
Frontotemporal Dementia (FTD) and Alzheimer’s disease have a profound impact on both individuals diagnosed with these conditions and their caregivers. The emotional, financial, and practical challenges faced by those affected can be overwhelming. It is crucial to provide support, resources, and guidance to help navigate this difficult journey.
Emotional Impact
Receiving a diagnosis of FTD or Alzheimer’s can be devastating for individuals and their families. The cognitive and behavioral changes associated with these conditions can cause high levels of stress, anxiety, and confusion. Individuals may experience feelings of grief, loss, and frustration as they witness their decline in abilities and independence. Caregivers often grapple with a range of emotions, including sadness, guilt, and frustration, as they witness the changes in their loved ones and shoulder the responsibility of caregiving.
Financial Impact
The financial burden of Frontotemporal Dementia and Alzheimer’s can be significant. As the diseases progress, individuals may require specialized medical care, including medications, therapies, and in-home assistance. These costs can quickly accumulate, placing strain on both individuals and their families. Caregivers may need to reduce their working hours or leave their jobs entirely to provide care, leading to a loss of income and financial stability.
Practical Challenges
Living with FTD or Alzheimer’s can present numerous practical challenges. Basic daily tasks such as managing finances, cooking meals, and personal hygiene may become increasingly difficult for individuals. Caregivers often bear the responsibility of helping with these tasks, as well as coordinating medical appointments and ensuring a safe living environment. Balancing caregiving duties with other responsibilities, such as work and family obligations, can be demanding and overwhelming.
Support and Resources
Fortunately, there are numerous support and resources available for individuals with Frontotemporal Dementia, Alzheimer’s, and their caregivers. Support groups provide a valuable platform for sharing experiences, receiving advice, and finding emotional support. Local community organizations and healthcare providers often offer educational programs and workshops to help individuals and caregivers better understand the diseases and learn effective coping strategies. Additionally, respite care services can provide temporary relief for caregivers, allowing them to take a break and prioritize self-care.
Current Research and Future Directions
The field of research on Frontotemporal Dementia (FTD) and Alzheimer’s disease is constantly evolving, with ongoing studies seeking to deepen our understanding of these neurodegenerative conditions. Researchers around the world are dedicated to finding new treatments, improving early detection methods, and identifying potential preventive measures.
Promising Areas of Study
One area of focus in FTD and Alzheimer’s research is the identification of biomarkers that can aid in accurate diagnosis. Biomarkers are measurable substances or characteristics that indicate the presence or progression of a disease. Researchers are investigating various biomarkers, such as specific proteins or changes in brain imaging, to develop more reliable diagnostic tests for FTD and Alzheimer’s.
Another exciting avenue of research is the exploration of genetic factors associated with these conditions. Scientists have identified certain genes, such as the MAPT gene in FTD and the APOE gene in Alzheimer’s, that play a role in disease susceptibility. Understanding the genetic mechanisms at play can potentially lead to targeted therapies and personalized treatment approaches.
Advancements in Treatment
Researchers are also actively working to develop new treatments for FTD and Alzheimer’s. While there is currently no cure for these diseases, several medications are available that can help manage symptoms and slow down cognitive decline. Ongoing clinical trials are testing the efficacy of new drugs and therapies in the hopes of finding more effective treatment options.
Furthermore, non-pharmacological interventions, such as cognitive rehabilitation programs and lifestyle modifications, are being explored as potential ways to improve the quality of life for individuals with FTD and Alzheimer’s. These interventions focus on maximizing cognitive function, promoting social engagement, and enhancing overall well-being.
Potential Future Directions
The future of FTD and Alzheimer’s research holds great promise. Scientists are investigating innovative approaches, such as gene therapies and immunotherapies, that aim to modify the underlying disease processes and halt or reverse the progression of these conditions.
Additionally, advancements in technology, such as artificial intelligence and wearable devices, are being explored for their potential in early detection and monitoring of FTD and Alzheimer’s. These technological tools can help identify subtle changes in behavior, cognition, or biological markers that may indicate the onset of the disease, enabling timely interventions.
| Research Area | Key Findings |
|---|---|
| Biomarker identification | Specific proteins and brain imaging changes being investigated as potential diagnostic markers |
| Genetic factors | MAPT gene in FTD and APOE gene in Alzheimer’s linked to disease susceptibility |
| New treatments | Ongoing clinical trials testing the efficacy of medications and non-pharmacological interventions |
| Innovative approaches | Gene therapies and immunotherapies showing promise for modifying disease processes |
| Advancements in technology | Artificial intelligence and wearable devices being explored for early detection and monitoring |
Conclusion
Frontotemporal Dementia and Alzheimer’s disease are two distinct neurodegenerative conditions that impact individuals in different ways. While both conditions involve cognitive decline and memory loss, Frontotemporal Dementia primarily affects behavior and language, whereas Alzheimer’s disease primarily affects memory and cognition.
Frontotemporal Dementia is characterized by changes in personality, social conduct, and impaired speech and language abilities. On the other hand, Alzheimer’s disease is marked by memory loss, confusion, and difficulty with daily tasks. The differences in symptoms can help healthcare professionals differentiate between the two disorders.
In terms of progression, Frontotemporal Dementia typically progresses rapidly, with symptoms becoming more severe over a shorter period. Alzheimer’s disease, on the other hand, progresses slowly and steadily, with symptoms worsening gradually over time. Understanding the distinctive progression patterns can aid in diagnosis and treatment planning.
When it comes to treatment, there is no cure for either condition. However, management strategies for Frontotemporal Dementia focus on behavioral interventions, while Alzheimer’s treatment often includes medications aimed at improving cognitive function. Caregiver support and resources play a crucial role in helping individuals and their loved ones navigate the challenges associated with both conditions.
FAQ
How is Frontotemporal Dementia different from Alzheimer's?
Frontotemporal Dementia (FTD) and Alzheimer's disease are both types of dementia, but they affect different areas of the brain and manifest with different symptoms. FTD primarily affects the frontal and temporal lobes of the brain, leading to changes in behavior, personality, and language skills. In contrast, Alzheimer's primarily affects the hippocampus and other areas involved in memory, resulting in memory loss and cognitive decline. The progression and treatment options for each condition also differ.
What are the symptoms of Frontotemporal Dementia versus Alzheimer's?
Frontotemporal Dementia is characterized by behavioral changes, such as impulsivity, apathy, and social disinhibition, as well as language difficulties. Alzheimer's disease, on the other hand, is characterized by memory loss, confusion, and disorientation. While both conditions may eventually exhibit overlapping symptoms, the initial presentation is typically different.
How is Frontotemporal Dementia diagnosed compared to Alzheimer’s?
The diagnosis of Frontotemporal Dementia involves a comprehensive evaluation of symptoms, medical history, and neuropsychological testing. Brain imaging scans, such as MRI or PET, may also be utilized to assess changes in the brain. Alzheimer's disease is diagnosed through a combination of clinical evaluation, cognitive assessments, and brain imaging. Differentiating between the two conditions can be challenging, but specialized testing and consultation with neurologists or geriatricians can help in making an accurate diagnosis.
How does Frontotemporal Dementia progress compared to Alzheimer's?
Frontotemporal Dementia tends to progress more rapidly than Alzheimer's disease, with individuals experiencing a gradual decline in cognitive abilities and behavioral changes over time. In contrast, Alzheimer's disease progresses gradually, typically starting with memory problems and eventually affecting multiple cognitive domains as the disease advances.
What are the available treatment options for Frontotemporal Dementia versus Alzheimer's?
Currently, there is no cure for either Frontotemporal Dementia or Alzheimer's disease. However, there are management strategies that can help alleviate symptoms and improve the quality of life for individuals with these conditions. Treatment approaches may involve medication, therapy (such as speech therapy or occupational therapy), and supportive care. The specific treatment plan will depend on the individual's symptoms and needs.
What is the prognosis for Frontotemporal Dementia compared to Alzheimer's?
The prognosis for Frontotemporal Dementia is generally poor, with a shorter life expectancy compared to individuals with Alzheimer's disease. Frontotemporal Dementia typically progresses more rapidly and can lead to severe disability within a few years. Alzheimer's disease, while also progressive, may progress more slowly, allowing individuals to maintain a higher level of independence for a longer period.
ACIBADEM Healthcare Group Hospitals and Clinics
With a network of hospitals and clinics across 5 countries, including 40 hospitals, ACIBADEM Healthcare Group has a global presence that allows us to provide comprehensive healthcare services to patients from around the world. With over 25,000 dedicated employees, we have the expertise and resources to deliver unparalleled healthcare experiences. Our mission is to ensure that each patient receives the best possible care, supported by our commitment to healthcare excellence and international healthcare standards. Ready to take the first step towards a healthier future? Contact us now to schedule your Free Consultation Health session. Our friendly team is eager to assist you and provide the guidance you need to make informed decisions about your well-being. Click To Call Now !*The information on our website is not intended to direct people to diagnosis and treatment. Do not carry out all your diagnosis and treatment procedures without consulting your doctor. The contents do not contain information about the therapeutic health services of ACIBADEM Health Group.